Transmedics Group Inc
NASDAQ:TMDX
Transmedics Group Inc
NASDAQ:TMDX
Price:
80.58
USD
5.51%
Market Closed
Market Cap:
2.7B
USD
Balance Sheet
Balance Sheet Decomposition
Transmedics Group Inc
Transmedics Group Inc
| Current Assets | 497.2m |
| Cash & Short-Term Investments | 336.7m |
| Receivables | 97.7m |
| Other Current Assets | 62.8m |
| Non-Current Assets | 306.9m |
| PP&E | 292.5m |
| Intangibles | 13.7m |
| Other Non-Current Assets | 708k |
Balance Sheet
Transmedics Group Inc
Transmedics Group Inc
Currency: USD
Millions
Annual
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
12
|
20
|
20
|
25
|
26
|
201
|
395
|
337
|
|
| Cash Equivalents |
12
|
20
|
20
|
25
|
26
|
201
|
395
|
337
|
|
| Short-Term Investments |
13
|
0
|
61
|
101
|
67
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
3
|
7
|
7
|
6
|
28
|
64
|
98
|
|
| Accounts Receivables |
1
|
3
|
7
|
7
|
6
|
28
|
64
|
98
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
8
|
9
|
11
|
12
|
15
|
21
|
44
|
47
|
|
| Other Current Assets |
1
|
2
|
2
|
2
|
6
|
3
|
8
|
16
|
|
| Total Current Assets |
34
|
35
|
100
|
147
|
119
|
252
|
511
|
497
|
|
| PP&E Net |
3
|
4
|
5
|
5
|
16
|
24
|
180
|
292
|
|
| PP&E Gross |
3
|
4
|
5
|
5
|
16
|
24
|
180
|
292
|
|
| Accumulated Depreciation |
4
|
5
|
6
|
8
|
10
|
13
|
21
|
41
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
12
|
12
|
|
| Other Long-Term Assets |
1
|
4
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
12
|
12
|
|
| Total Assets |
37
N/A
|
42
+14%
|
105
+150%
|
152
+44%
|
135
-11%
|
277
+105%
|
706
+155%
|
804
+14%
|
|
| Liabilities | |||||||||
| Accounts Payable |
4
|
5
|
7
|
1
|
7
|
3
|
13
|
10
|
|
| Accrued Liabilities |
5
|
7
|
8
|
10
|
16
|
20
|
40
|
48
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
1
|
0
|
0
|
0
|
2
|
2
|
|
| Total Current Liabilities |
11
|
13
|
16
|
12
|
23
|
24
|
55
|
60
|
|
| Long-Term Debt |
7
|
34
|
34
|
35
|
35
|
59
|
506
|
509
|
|
| Other Liabilities |
2
|
2
|
0
|
2
|
9
|
7
|
8
|
6
|
|
| Total Liabilities |
19
N/A
|
48
+149%
|
51
+6%
|
48
-5%
|
67
+39%
|
90
+34%
|
569
+533%
|
575
+1%
|
|
| Equity | |||||||||
| Common Stock |
187
|
187
|
424
|
502
|
511
|
666
|
641
|
697
|
|
| Retained Earnings |
312
|
336
|
370
|
398
|
442
|
479
|
504
|
468
|
|
| Additional Paid In Capital |
144
|
144
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
18
N/A
|
6
N/A
|
55
N/A
|
104
+90%
|
68
-35%
|
187
+176%
|
137
-27%
|
229
+67%
|
|
| Total Liabilities & Equity |
37
N/A
|
42
+14%
|
105
+150%
|
152
+44%
|
135
-11%
|
277
+105%
|
706
+155%
|
804
+14%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
20
|
20
|
21
|
27
|
28
|
32
|
33
|
34
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
